Ipamorelin – Research-Grade Synthetic Growth Hormone–Releasing Peptide
Ipamorelin is a synthetic pentapeptide belonging to the growth hormone secretagogue class of research compounds. It is structurally distinct from endogenous growth hormone–releasing hormone (GHRH) and is characterized by the inclusion of non-proteinogenic amino acid residues that influence stability and receptor interaction behavior. In laboratory research settings, Ipamorelin is utilized as a reference material for studying ghrelin-related receptor models, peptide–receptor binding dynamics, and comparative signaling mechanisms associated with growth hormone release pathways.
Due to its short, well-defined structure, Ipamorelin exhibits physicochemical properties that differ from longer hypothalamic peptides and protein hormones. This makes it a useful tool for examining receptor-specific signaling, peptide stability, and degradation kinetics in vitro without the complexity introduced by extended peptide chains or carrier modifications. Its consistent synthetic profile supports controlled use in mechanistic assays, receptor interaction studies, and exploratory biochemical research conducted under controlled laboratory conditions.
Related research compounds
GHRP-2 · GHRP-6 · Hexarelin · CJC-1295 (No DAC) · CJC-1295 (w/o DAC) + Ipamorelin (Blend) · Sermorelin
Documentation and methods
Analytical testing · How to read a COA · Batch COAs · Storage and handling · What are research peptides
Important Information About This Research Product
- 1 Your vials are not empty. The lyophilized material may collect at the bottom of the vial and can appear minimal prior to inspection.
- 2 All products are supplied as lyophilized (freeze-dried) powder and require reconstitution. Bacteriostatic water is not supplied.
- 3 Store in a dry, cool, and dark environment away from UV exposure. For optimal preservation, storage at approximately 4°C is recommended.
- 4 This material is strictly for laboratory and research use only. No instructions regarding reconstitution, dosing, or administration can be provided.
